ScholarX: KWON, GHEE YOUNG

Detailed Information

KWON, GHEE YOUNG (권기영)

Medicine (Medicine)

Research Area

Tel 02-3410-2770
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

prostate cancer:6||Urothelial carcinoma:6||acute kidney injury:4||Prostate cancer:4||adrenal gland:4||Immunohistochemistry:4||magnetic resonance imaging:3||Proteinuria:3||Mutation:3||prognosis:3||Urinary bladder neoplasms:3||onychodermis:3||computed tomography:3||immunotherapy:3||Renal cell carcinoma:3||mutation:2||SPOP protein:2||nail matrix:2||nail unit:2||Metastasis:2||immunohistochemistry:2||Ischemiareperfusion injury:2||diffusionweighted imaging:2||onychofibroblast:2||Stent:2||inflammation:2||Immunotherapy:2||castrationresistant prostate cancer:2||pheochromocytoma:2||ischemiareperfusion injury:2||prostate:2||chronic kidney disease:2||kidney:2||kidney neoplasms:2||CD274:2||regulatory T cells:2||MRI:2||renal cell carcinoma:2||Magnetic resonance imaging:2||Angioplasty:2||Multiple myeloma:2||Renal artery stenosis:2||IgA nephropathy:2||Fanconi syndrome:2||Endothelial cell crossmatch:1||Epithelialmesenchymal transition:1||Epithelium:1||EpsteinBarr virus:1||FGFR:1||FGFR3:1||Familial juvenile hyperuricemic nephro:1||Fluoropyrimidine:1||Fusion:1||Gastric:1||Genes:1||Genomic feature:1||Germ cell tumour:1||Glands:1||Graftversushost disease:1||Grafts:1||HRAS:1||HSP90:1||HenochSchonlein purpura:1||Hepatectomy:1||IMDC poorrisk:1||Immune checkpoint inhibitors:1||Interstitial Nephritis:1||Interstitial nephritis:1||Intraductal carcinoma:1||Intraoperative complications:1||Ischemic acute kidney injury:1||Kidney injury molecule1:1||Kidney transplantation:1||Lamina propria:1||Liver regeneration:1||Liver steatosis:1||Liver transplantation:1||Living donors:1||Locoregional recurrence:1||Lowrisk:1||Medullary Carcinoma:1||Megalocytic Interstitial Nephritis:1||Membranous nephropathy:1||Methylation:1||Microsurgery:1||Miles’ operation:1||Monoclonal antibody:1||Monoclonal gammopathy:1||Monoclonal gammopathy of renal significance (MGRS):1||Monoclonal gammopathy of undetermined significance:1||Muscleinvasive:1||Neoadjuvant chemoradiotherapy:1||Neoadjuvant chemotherapy:1||Neoadjuvant therapy:1||Neoplasm:1||Nephrectomy:1||Nephropathy:1||Neuroendocrine Carcinoma:1||Neuroendocrine Tumor:1||Neutrophil gelatinaseassociated lipocalin:1||Nextgeneration sequencing:1||Nivolumab:1||NonHLA antibodies:1||Onychodermis:1||Onychofibroblast:1||Onychomatricodermis:1||Outcome:1||PCR:1||PIRADS:1||PPAR gamma:1||Palliative chemotherapy:1||Patterns of locoregional recurrence:1||Peripheral zone:1||Plasma cell disorder:1||Prediction:1||Proctitis:1||Prognosis:1||Programmed cell death 1 ligand 1:1||Prostate neoplasm:1||Prostatic Neoplasms:1||RCC:1||ROR2 tyrosine kinase:1||Radiation protection:1||RealTime Polymerase Chain Reaction:1||Receptor fibroblast growth factor, type 3:1||Retrospective:1||SOX9:1||SP263:1||SRM:1||Salvage:1||Screening panels:1||TERT promoter mutation:1||Target therapy:1||Thrombosis:1||Tomography:1||Transitional cell:1||Transperineal US:1||Treatment outcome:1||Triphala:1||Upper urinary tract:1||Urachal cancer:1||Ureter:1||Urinary bladder:1||Urography:1||Uromodulin:1||Urothelial:1||Vancomycin:1||Vascular purpura:1||Vimentin:1||Wholeexome sequencing:1||Wholetranscriptome sequencing:1||acute interstitial nephritis:1||acute tubular necrosis:1||adrenal gland, neoplasm:1||adrenal neoplasms:1||adult:1||androgen receptor:1||androgen receptor variant 7:1||angiomyolipoma:1||apoptosis:1||apparent diffusion coefficient:1||apparent diffusion coefficient (ADC):1||atypical melanocyte:1||biomarker:1||biopsy:1||body mass index:1||bone marrow ablation:1||bruceantin:1||cKit:1||cmet:1||carcinoma:1||chemokines:1||chimerism:1||cisplatin:1||cisplatin nephrotoxicity:1||clinical interpretation:1||combined kidney and bone marrow transplantation:1||comparative study:1||computed tomography (CT):1||computed tomography, enhancement:1||confidence interval:1||contrast enhancement:1||cynomolgus monkey:1||cytokines:1||dermatomyositis:1||diabetic nephropathy:1||diet:1||diffuse proliferative glomerulonephritis:1||diffusionweighted MRI (DWI):1||docetaxel:1||donor:1||elastin:1||endstage renal disease:1||epidermal growth factor receptor:1||extragonadal teratoma:1||fistulous extension:1||flow cytometry:1||fludarabine monophosphate:1||follicular dendritic cell tumor:1||frozen section:1||gastric:1||gastritis:1||glomerulonephritis:1||glomerulus basement membrane:1||graft survival:1||hair follicle:1||highfat diet:1||highsalt diet:1||histological type:1||human umbilical cord bloodderived mesenchymal stem cells:1||human umbilical cordderived mesenchymal stem cells:1||immune checkpoint inhibitors:1||immunoglobulin kappachains:1||immunologic micromilieu:1||immunomodulation:1||immunosuppressive agents:1||in:1||induction therapy:1||inflammatory pseudotumor:1||interchangeability:1||intraductal papillary mucinous tumor:1||islets of Langerhans transplantation:1||isochromosome 12p:1||kidney transplantation:1||lung cancer:1||lymphocytes:1||mRNA expression:1||mastocytosis:1||mediastinal teratoma:1||mediator complex subunit 12:1||melanoma:1||mesenchymal stem cells:1||mesenchyme:1||mesoblastic:1||metastasis:1||multiple myeloma:1||mutation analysis:1||neoplasm:1||neoplasms:1||nephroma:1||next generation sequencing:1||onychofibrobl:1||onychomatricodermis:1||overall survival:1||pancreas:1||paraganglioma:1||parthanatos:1||perfusion:1||peripheral zone:1||permanent section:1||poly(ADPribose) polymerase (PARP) inhibitor:1||prognostic factor:1||prostate gland:1||prostate neoplasms:1||proteinuria:1||pyrosequencing:1||recovery:1||reliability:1||renal ischemiareperfusion injury:1||repair:1||reproducibility:1||risk factor:1||rosmarinic acid:1||seminoma:1||small renal mass:1||spleen:1||squamous cell carcinoma:1||staging:1||stomach:1||subungual melanoma in situ:1||sunitinib:1||syphilis:1||targete:1||teratoma:1||tolerance:1||transition zone:1||translational immunology:1||treponema pallium:1||tumor biomarkers:1||tumor microenvironment:1||tumor microenvironments:1||tumor suppressor:1||tumorinfiltrating:1||ureteral cancer:1||urothelial:1||urothelial carcinoma:1||urothelial eddy:1||uterine cervical cancer:1||variant:1||22C3:1||youngonset bladder cancer:1||AR splice variants:1||ARV7:1||Acquired cystic disease:1||Acute Kidney Injury:1||Adjuvant:1||Allogenic hematopoietic stem cell transplantation:1||AlphamethylacylCoA racemase:1||Androgen receptor:1||Anti angiotensin II type 1 receptor antibodies:1||Antiendothelial cell antibodies:1||Atezolizumab:1||BMI:1||Biomarker:1||Biopsy outcomes:1||Biopsy techniques:1||Bladder:1||Bladder cancer:1||CD13:1||CD24:1||CD40 ligand:1||CI:1||CT:1||Cancer:1||Carcinoid:1||Carcinoma:1||Carcinoma, renal cell:1||Chemotherapy:1||Cisplatin:1||Claudin7:1||Clinical implication:1||Collagen:1||Comparison:1||Computed tomography:1||Concurrent chemoradiotherapy:1||Cyclophosphamide:1||Cytotoxic therapy:1||Diabetic kidney disease:1||Diabetic nephropathy:1||Diffusionweighted MR imaging:1||Dual blockade:1||Ecadherin:1||ERCC1:1||ERG:1||

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE